Publication: Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses.
| cris.virtualsource.author-orcid | 29e2b3bf-583b-46e2-ba93-110e2f417cad | |
| cris.virtualsource.author-orcid | a4f6ff84-4892-4327-8844-f07d81f751bd | |
| cris.virtualsource.author-orcid | 049754e9-726c-4609-8be1-8c0a023eb81b | |
| cris.virtualsource.author-orcid | 54c32983-0197-4cba-b58f-e62b74b28281 | |
| datacite.rights | open.access | |
| dc.contributor.author | Siddharta, Anindya | |
| dc.contributor.author | Pfänder, Stephanie | |
| dc.contributor.author | Vielle, Nathalie Jane | |
| dc.contributor.author | Dijkman, Ronald | |
| dc.contributor.author | Friesland, Martina | |
| dc.contributor.author | Becker, Britta | |
| dc.contributor.author | Yang, Jaewon | |
| dc.contributor.author | Engelmann, Michael | |
| dc.contributor.author | Todt, Daniel | |
| dc.contributor.author | Windisch, Marc P | |
| dc.contributor.author | Brill, Florian H | |
| dc.contributor.author | Steinmann, Joerg | |
| dc.contributor.author | Steinmann, Jochen | |
| dc.contributor.author | Becker, Stephan | |
| dc.contributor.author | Alves, Marco | |
| dc.contributor.author | Pietschmann, Thomas | |
| dc.contributor.author | Eickmann, Markus | |
| dc.contributor.author | Thiel, Volker Earl | |
| dc.contributor.author | Steinmann, Eike | |
| dc.date.accessioned | 2025-01-08T20:24:49Z | |
| dc.date.available | 2025-01-08T20:24:49Z | |
| dc.date.issued | 2017-03-15 | |
| dc.description.abstract | The World Health Organization (WHO) published 2 alcohol-based formulations to be used in healthcare settings and for outbreak-associated infections, but inactivation efficacies of these products have not been determined against (re-)emerging viruses. In this study, we evaluated the virucidal activity of these WHO products in a comparative analysis. Zika virus (ZIKV), Ebola virus (EBOV), severe acute respiratory syndrome coronavirus (SARS-CoV), and Middle East respiratory syndrome coronavirus (MERS-CoV) as (re-)emerging viral pathogens and other enveloped viruses could be efficiently inactivated by both WHO formulations, implicating their use in healthcare systems and viral outbreak situations. | |
| dc.description.numberOfPages | 5 | |
| dc.description.sponsorship | Institut für Virologie und Immunologie (IVI) | |
| dc.description.sponsorship | Department of Infectious Diseases and Pathobiology (DIP) | |
| dc.identifier.doi | 10.7892/boris.112064 | |
| dc.identifier.pmid | 28453839 | |
| dc.identifier.publisherDOI | 10.1093/infdis/jix046 | |
| dc.identifier.uri | https://boris-portal.unibe.ch/handle/20.500.12422/199771 | |
| dc.language.iso | en | |
| dc.publisher | Oxford University Press | |
| dc.relation.ispartof | Journal of infectious diseases | |
| dc.relation.issn | 0022-1899 | |
| dc.relation.organization | DCD5A442C0BAE17DE0405C82790C4DE2 | |
| dc.relation.organization | DCD5A442C1CCE17DE0405C82790C4DE2 | |
| dc.relation.organization | DCD5A442C208E17DE0405C82790C4DE2 | |
| dc.subject | Ebola virus SARS WHO Zika virus MERS | |
| dc.subject.ddc | 600 - Technology::630 - Agriculture | |
| dc.subject.ddc | 500 - Science::570 - Life sciences; biology | |
| dc.subject.ddc | 600 - Technology::610 - Medicine & health | |
| dc.title | Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses. | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| dspace.file.type | text | |
| oaire.citation.endPage | 906 | |
| oaire.citation.issue | 6 | |
| oaire.citation.startPage | 902 | |
| oaire.citation.volume | 215 | |
| oairecerif.author.affiliation | Institut für Virologie und Immunologie (IVI) | |
| oairecerif.author.affiliation | Institut für Virologie und Immunologie (IVI) | |
| oairecerif.author.affiliation | Institut für Virologie und Immunologie (IVI) | |
| oairecerif.author.affiliation | Institut für Virologie und Immunologie (IVI) | |
| oairecerif.author.affiliation | Department of Infectious Diseases and Pathobiology (DIP) | |
| oairecerif.author.affiliation2 | Institut für Virologie und Immunologie (IVI) | |
| unibe.contributor.role | creator | |
| unibe.contributor.role | creator | |
| unibe.contributor.role | creator | |
| unibe.contributor.role | creator | |
| unibe.contributor.role | creator | |
| unibe.contributor.role | creator | |
| unibe.contributor.role | creator | |
| unibe.contributor.role | creator | |
| unibe.contributor.role | creator | |
| unibe.contributor.role | creator | |
| unibe.contributor.role | creator | |
| unibe.contributor.role | creator | |
| unibe.contributor.role | creator | |
| unibe.contributor.role | creator | |
| unibe.contributor.role | creator | |
| unibe.contributor.role | creator | |
| unibe.contributor.role | creator | |
| unibe.contributor.role | creator | |
| unibe.contributor.role | creator | |
| unibe.date.licenseChanged | 2019-10-24 02:30:26 | |
| unibe.description.ispublished | pub | |
| unibe.eprints.legacyId | 112064 | |
| unibe.journal.abbrevTitle | J INFECT DIS | |
| unibe.refereed | true | |
| unibe.subtype.article | journal |
Files
Original bundle
1 - 1 of 1
- Name:
- jix046.pdf
- Size:
- 606.74 KB
- Format:
- Adobe Portable Document Format
- File Type:
- text
- License:
- https://creativecommons.org/licenses/by-nc-nd/4.0
- Content:
- published